AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
AstraZeneca has 29.8 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: AstraZeneca (onglyza.com)
This is a rare example of a zero-bullshit utility site. It functions as a regulatory transparency layer with almost no promotional intent. The only measurable BS is found in the lack of technical meta-information and structured data.
Implement Organization and Brand schema to provide search engines with a verified digital footprint of the AstraZeneca entity. Populate the meta_description tags with specific summaries of the medications directory to improve technical SEO authority. Add a specific real-world evidence link or a summary statistic to the Help affording your medicines section to ground the value claim in substance. Ensure the heading hierarchy is optimized by consolidating redundant H1 titles across the internal pages to reduce search-engine-level noise.
Information density is exceptionally high due to the lack of marketing fluff. Heading markers are almost exclusively specific named entities, such as ONGLYZA saxagliptin tablets or CALQUENCE acalabrutinib tablets, rather than power-word-heavy slogans. The body substance ratio is high because the text consists of functional links to technical Prescribing Information and Health Care Professional sites. Only the H2 Help affording your medicines contains minor generic language, which is negligible compared to the 40+ specific product listings.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is zero semantic drift across the analyzed pages. The homepage H1 AstraZeneca medications perfectly aligns with the content of all sub-pages, which function as identical lists of the company’s pharmaceutical portfolio. The hero section makes no breakthrough claims that are not immediately supported by links to clinical Prescribing Information. The target audience remains consistently split between US residents, healthcare professionals, and patients across all page iterations.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
Trust theatre is absent as the site does not utilize unverified third-party reviews or award logos. The review_count is 0 across all pages, and the site relies on a proof_links_code of 1, which represents the regulatory requirement for FDA MedWatch reporting. While the affordance section makes a value claim about ensuring medicine access, it does not use ‘trust theatre’ tactics like fake counters or generic testimonials.
Proof density is high, with a nearly 1:1 ratio of product mentions to verifiable proof paths. Each drug listed under an H3 header includes a link to full Prescribing Information, which is the gold standard for clinical proof in this industry. The inclusion of Boxed WARNINGS for specific drugs like BRILINTA and SYMLIN further demonstrates a high substance-to-signal ratio, prioritizing safety disclosures over marketing fluff.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site avoids most value proposition clichés, though it uses standard industry boilerplate such as information contained below is intended for US residents only. The value proposition is entirely unique to the brand because the content is a proprietary list of patented medications. Template language is minimal, restricted to utility links and the affordability block. This content could not be copy-pasted onto a competitor because the H3 headers are specific brand names owned by the entity.
The primary authority gap is technical rather than rhetorical. The schema_json is null across all pages, meaning the site fails to use structured data to verify its Organization identity or connect its products to known databases. There is also a technical credibility gap in the meta data, as the meta_description is empty for every page. However, the authority of the brand is established through the inclusion of the 1-800-236-9933 side effect reporting line and the reference to FDA MedWatch.
There is no marketing-to-performance disconnect because the site makes almost no performance claims. It functions as a directory of facts rather than a sales pitch for outcomes. The only minor disconnect is the lack of specific affordability data to back up the H2 Help affording your medicines section on the actual page. Otherwise, every product mentioned is backed by a direct path to its regulatory filings.
Medical Devices, Pharma & Biotech BS: AstraZeneca (onglyza.com)
The site content is a 100% match for the Pharmaceutical and Biotech industry. It serves as a regulatory-compliant directory of drug products, providing direct access to Prescribing Information and adverse event reporting mechanisms.
When your canonical, redirect, and final URL disagree, the model treats each version as a separate entity. Study the Canonical Integrity Framework Guide and see why stable identity is the prerequisite for AI driven retrieval.
“The score of 11 is driven primarily by technical authority gaps (missing schema and meta descriptions) rather than content bullshit. The site earns near-perfect scores for Information Density and Semantic Coherence because it avoids marketing jargon entirely. The high substance of the 40+ pharmaceutical listings and Prescribing Information links effectively neutralizes any commodity or fluff penalties.”